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The primary mucinous cystadenocarcinoma (MCA) of the 
breast is an extremely rare neoplasm. The most common sites of 
MCA include the ovary, pancreas and appendix. Only 13 cases 
of primary MCA of the breast have been reported, since Koenig 
and Tavassoli reported the first 4 cases of MCA in 1998 (Tables 
1, 2).1-10 The breast MCAs showed unique clinico-pathologic 
characteristics, distinguishable from ordinary mucinous carci-
noma (MC) and signet ring cell carcinoma. Clinically, MCA in 
the breast is found in postmenopausal women and present as a 
relatively large, cystic mass with a favorable prognosis. Micro-
scopically, the cysts are lined by tall columnar mucinous cells, 
resembling those of endocervical glands. The MCA tumors 
demonstrate consistent immunohistochemical staining (IHC) 
results with negative estrogen receptor (ER), negative proges-
terone receptor (PR), positive cytokeratin 7 (CK7), and nega-
tive cytokeratin 20 (CK20). The c-erbB2 IHC results are avail-
able in five cases.4,5,7-9 They are negative in four and positive in 
one with HER-2 gene amplification confirmed by fluorescence 
in situ hybridization.9 
In the case being reported here, the mass was only 9 mm, 
though the size before core biopsy was assessed to be 14 mm by 
ultrasound examination. Other characteristics of this new case 
share those clinical, cytological, and histopathological findings 
described in previously published cases (Tables 1, 2). In this pa-
per, we present a rare cytologic finding of primary MCA in the 
breast and the characteristics of mucin (MUC).
CASE REPORT
Clinical summary
A 59-year-old postmenopausal woman presented with an ill-
defined, hard mass in her left breast for a year. Radiologic evalu-
ations demonstrated a hypo-echoic mass (14 mm) with a specu-
lated margin in ultrasonography and a focal asymmetric density 
in the upper medial portion by mammography. Fine needle as-
piration followed by needle biopsy was performed with the di-
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agnosis of MC and invasive carcinoma with abundant mucin 
pool formation, respectively. She underwent partial mastectomy 
with sentinel lymph node biopsy. The sentinel lymph node was 
free from metastasis. She has been followed for 3 months with 
chemotherapy for adjuvant treatment and remains disease-free.
Pathologic findings
The aspiration showed a few scattered, variably sized, irregu-
lar clusters of columnar cells in the greenish blue mucinous back-
ground with necrotic debris. The columnar cells contained abun-
dant mucin vacuoles in cytoplasm which had displaced their 
nuclei. The nuclear membrane was irregular and sharply angu-
lated and the nuclei revealed a coarse chromatin pattern with 
prominent nucleoli (Fig. 1).
On gross examination, the cut surface showed an irregular, 
white to tan, solid and firm mass (9×7 mm), with a glistening 
appearance. Most MCAs in previous reports have demonstrated 
grossly cystic cut surfaces, except one case of MCA reported 
from Koenig and Tavassoli2 in 1998.1,3-10 The case in 1998 was 
small in size (8 mm) and had a grossly solid appearance. The 
present case was 9 mm in maximal diameter and did not con-
tain a macroscopic cyst. It is assumed that the small size of the 
MCA meant that it did not produce enough mucin to fill out 
and dilate cysts and ductal structures. The microscopic findings 
revealed a few cysts and ductal carcinoma in situ, adjacent to the 
invasive carcinoma. The cysts were lined by a single layer of tall 
columnar mucinous cells with focal areas of micropapillary struc-
tures, resembling those of the uterine endocervix. The luminal 
Table 1. Clinical feature of mucinous cystadenocarcinoma in the breast
Case Age (yr) Size (mm) TNM Duration Operation
Adjuvant 
treatment
Follow-up
11 79 60 T2N0M0 N/A MRM No Died with other reason 9 yr
22 54 190 T3N2M0 N/A MRM/c LND No Alive with no evidence of disease 24 mo
32 67 23 T2N0M0 N/A MRM/c LND No Alive with no evidence of disease 22 mo
42 49 85 T3N0M0 N/A MRM/c LND Chm+RT Alive with no evidence of disease 11 mo
52 61 8 T1N0M0 N/A Lumpectomy/c LND No N/A Recent
63 74 100 T3N0M0 2 yr MRM/c LND No Alive with no evidence of disease N/A
74 96 20 T2N2M0 5 yr Lumpectomy/c LND No Died with other reason 46 mo
85 65 30 T2N0M0 >3 mo MRM/c LND No Alive with no evidence of disease 8 mo
96 51 40 T2N0M0 N/A Lumpectomy N/A N/A N/A
107 55 25 T2N0M0 N/A Lumpectomy No Alive with no evidence of disease 6 mo
118 52 100 T3N0M0 N/A Excision Tamoxifen Alive with no evidence of disease 24 mo
129 73 45 T2N0M0 Few months MRM/c LND N/A N/A N/A
1310 65 30 T2N0M0 N/A PM/c LND No Alive with no evidence of disease 6 mo
Present case 59 9 T1N0M0 1 yr PM/c LND Chm Alive with no evidence of disease 3 mo
TNM, tumor-node-metastasis; N/A, not acquired; MRM, modified radical mastectomy; c LND, with lymph node dissection; Chm+RT, chromatography+radia-
tion therapy; PM, partial mastectomy. 
Table 2. Immunohistochemical feature of mucinous cystadenocarcinoma in the breast
Case No. ER PR c-erbB2 CK7 CK20 CDX-2 Ki-67 (%) p53 (%)
11
22 N N P N 40
32 N N P N 30
42 N N P N 70
52 N N P N 50
63 N P N 21.80 N
74 N N N 35 P (5)
85 N N N P Focal P N 20.50 P
96 N N P N N
107 N N N P N 90
118 P N N N N
129 N N 2++ P N N
1310 N N P N
Present case N N 2++ P N N 5 P (5)
ER, estrogen receptor; PR, progesterone receptor; CK7, cytokeratin 7; CK20, cytokeratin 20; N, negative; P, positive.
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space contained mucin (Fig. 2). The invasive cancer area con-
tained an abundant mucin pool in stroma with floating cell clus-
ters. The floating cells contained mucin vacuoles in cytoplasm 
displacing atypical nuclei to the periphery. 
Special staining and IHC on paraffin embedded tissue were 
performed. Both intracytoplasmic and extracytoplasmic mucin 
were stained by periodic acid-Schiff with diastase, alcian blue 
and mucicarcine, representing the acidic and neutral nature of 
mucin. The tumor cells were positive for CK7 and negative for 
CK20 and CDX-2. The IHC for MUC proteins was performed. 
The cancer cells were positive for MUC5 and MUC1 and nega-
tive for MUC2 and MUC6. Mucin of the intracytoplasm and 
stroma revealed positivity for MUC5 and negativity for the oth-
er MUC proteins (MUC1, MUC2, and MUC6). The hormone 
receptors, ER and PR, were negative. The c-erbB2 was 2-posi-
tive (Fig. 3), but silver in situ hybridization demonstrated no 
amplification of the HER-2 gene. 
DISCUSSION
In the breasts, mucin-producing tumors are classified as MC, 
signet ring cell carcinoma (SRC), or mucocele-like tumors.11 
The differences among mucin-containing tumors in the breast 
are shown in Table 3.12-14 MC and mucocele-like tumors are 
characterized by abundant extracellular mucin with floating 
neoplastic cells that do not contain intracytoplasmic mucin. 
The mucocele-like tumor is benign and the floating tumor cells 
are very rare. MC is specific type of invasive ductal caricinoma. 
The cytologic features show tight clusters of bland looking cells 
with moderate cellularity in the mucinous background.13 SRC 
demonstrates mucin only in the cytoplasm. The aspiration re-
veals a cellular smear of pleomorphic and plasmocytoid cells 
with intracytoplasmic mucin in the bloody or necrotic back-
ground.14 MCA has similar characteristics to both MC and SRC. 
The aspiration smears reveal tight clusters of mucin-containing 
cells of low to moderate cellularity in the background of muci-
nous and necrotic material. The histopathologic findings con-
firm both, intracytoplasmic and extracytoplasmic mucin. 
Mucin is a high molecular weight glycoprotein that consists 
of one protein core and O-linked carbohydrate side chains at-
tached.15 Epithelial cells produce two types of mucin. One is se-
cretory mucin (MUC2, MUC5, and MUC6) and the other is 
trans-membrane mucin (MUC1, MUC3, MCU4, MUC12, and 
MUC17).16 They are expressed differently according to the types 
of organs and tumors. For example, MC of the colon shows high 
positivity for MUC2.17 SRC of the colon shows MUC2 and 
MUC4 positivity.16 Among breast cancers, MC expresses main-
ly MUC2 along with a low level of MUC1, while SRC of the 
A B
Fig. 1. Cytologic features of mucinous cystadenocarcinoma. (A) A few scattered, variably sized, irregular clusters of columnar cells with pleo-
morphism and anisocytosis in a greenish blue mucinous background and necrotic debris. (B) The cells contain abundant mucin vacuoles in 
cytoplasm that attenuate and displace their nuclei. The nuclear membrane is irregular and sharply angulated and the nuclei reveal a coarse 
chromatin pattern with prominent nucleoli.
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breast has a high level of MUC1 expression with a variable level 
of MUC2.18 In the breasts, MUC5 is not frequently observed. 
MCs of the breast express MUC5 in only small proportions (less 
than 5%).19 In our case of MCA reported here, the MUC IHC 
demonstrates a high level of expression of MUC5 and no ex-
pression of MUC2 or MUC6. This mucin profile is different 
from ordinary mucinous carcinoma arising in the breast and 
other organs. MUC5-positive and MUC2-negative immuno-
profiles have not been reported before, in breast carcinoma.
Because of the rarity of mammary MCA, the diagnosis has to 
be made cautiously. Thus metastasis from distant organs should 
be initially considered. The usual immunoprofiles to rule out 
C
A
D
B
Fig. 2. Histologic features of mucinous cystadenocarcinoma. (A) The tumor shows an abundant mucin pool in stroma with floating cell clus-
ters. (B) The ductal carcinoma in situ is found in the form of small cysts, adjacent to the invasive carcinoma. The cysts are lined by a single 
layer of tall columnar mucinous cells with focal areas of micropapillary and small tufted structures, resembling those of the uterine endocer-
vix. (C) The invasive cells are pleomorphic and contained mucin vacuoles in cytoplasm displacing atypical nuclei to the periphery. (D) Both 
the intracytoplasmic and extracytoplasmic mucin are stained by alcian blue.
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Table 3. Comparison of mucin-producing tumors in the breast
Mucocle-like tumor Mucinous carcinoma Signet ring cell carcinoma MCA
Cytologic feature Background of smear Presence of mucin Presence of mucin Bloody, necrotic, clear Mucin, necrotic
Cohesiveness N/A Tight cluster Loosely cohesive group Tight cluster
Cellularity Scant Moderate High Low to moderate
Arrangement Monolalyered Monolayered, 3-D Monolayered 3-D
Cells in smear Lack of cytologic atypia Bland looking nuclei Plasmacytoid, pleomorphic Plasmacytoid, pleomorphic
Histologic feature Intracytoplasmic mucin Absent Absent Present Present
Extracelluar mucin Present Present Absent Present
Lining cells Flat or low cuboidal cells N/A N/A Tall columnar cells
Floating tumor cells Rarely present Present N/A Present
Associated lesion ADH, DCIS, IDC IDC ILC, IDC IDC
MCA, mucinous cystadenocarcinoma; N/A, not availale; ADH, atypical ductal hyperplasia; DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; ILC, 
infiltrating lobular carcinoma.
Fig. 3. Immunohistochemical staining of mucinous cystadenocarcinoma. The tumor cells are positive for cytekeratin 7 (A) and negative for 
cytokeratin 20 (B). The hormone receptors, estrogen receptor and progesterone receptor, are negative and the c-erbB2 is 2-positive (C). The 
tumor cells are positive for mucin (MUC) 1 (D) along the cytoplasmic membrane and negative for MUC2 (E). Mucin of the intracytoplasm and 
stroma reveal positivity for MUC5 (F).
A B C
D E F
metastasis from distant MCA are following: CK7 positive, CK20 
negative, and CDX-2 negative. These results can help to ex-
clude the possibility of metastatic MCA from the ovary, pancre-
as, and gastrointestinal tract. Being MUC5 positive and MUC2 
negative may be the unique characteristics of MCA in the breast, 
together with the immunoprofiles of being CK7 positive, CK20 
negative, CDX-2 negative, ER negative, and PR negative.
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